What are some high‑yield USMLE Step 1 questions and answers covering common clinical scenarios such as intussusception, bacterial meningitis, hypertensive emergency, anterior STEMI, folate‑deficiency macrocytic anemia, Kawasaki disease, pre‑eclampsia, non‑small cell lung carcinoma, and diabetic ketoacidosis?

High-Yield USMLE Step 1 Questions and Answers

Hypertensive Emergency Management

For hypertensive emergencies, labetalol or nicardipine should be your first-line agents in most clinical scenarios, with specific BP targets and timelines varying by the affected organ system 1.

Key Clinical Scenarios with Specific Targets:

Acute Coronary Event (Anterior STEMI)

• Target: Systolic BP <140 mmHg immediately
• First-line: Nitroglycerin
• Alternative: Urapidil or Labetalol
• Rapid BP control is essential to reduce myocardial oxygen demand 1

Hypertensive Encephalopathy

• Target: Reduce MAP by 20-25% immediately
• First-line: Labetalol (preferred because it preserves cerebral blood flow and doesn't increase intracranial pressure)
• Alternatives: Nitroprusside or Nicardipine 1

Acute Cardiogenic Pulmonary Edema

• Target: Systolic BP <140 mmHg immediately
• First-line: Nitroprusside or Nitroglycerin (always with loop diuretic)
• Alternative: Urapidil (with loop diuretic) 1

Pre-eclampsia/Eclampsia

• Target: Systolic BP <160 mmHg AND diastolic BP <105 mmHg immediately
• First-line: Labetalol or Nicardipine PLUS Magnesium sulfate
• This is a critical distinction—magnesium sulfate is mandatory for seizure prophylaxis 1

Common Pitfalls:

• Avoid excessive BP reduction (>50% decrease in MAP) in malignant hypertension—this causes ischemic stroke and death
• Withhold BP-lowering in acute ischemic stroke unless BP >220/120 mmHg or thrombolysis is planned
• ACE inhibitors in malignant hypertension produce unpredictable responses due to variable renin-angiotensin activation—start at very low doses only 1

Non-ST Elevation ACS Initial Management

Aspirin 160-325 mg non-enteric formulation immediately, followed by clopidogrel 300-600 mg loading dose, plus anticoagulation based on your invasive strategy 2.

Primary Therapeutic Measures:

• Oxygen: Only if saturation <90% (4-8 L/min)
• Nitrates: Sublingual or IV (hold if systolic BP <90 mmHg)
• Morphine: 3-5 mg IV/SC for pain control
• Oral beta-blocker: Especially with tachycardia or hypertension without heart failure signs
• Anticoagulation options: UFH, fondaparinux 2.5 mg SC daily, enoxaparin 1 mg/kg SC twice daily, or bivalirudin 2

Risk Stratification Determines Invasive Timing:

Urgent Invasive (immediate catheterization):

• Refractory angina (evolving MI without ST changes)
• Recurrent angina with ST-depression ≥2 mm or deep negative T-waves despite treatment
• Heart failure or hemodynamic instability
• Life-threatening arrhythmias (VF/VT) 2

Conservative Strategy (no early catheterization):

• No recurrent chest pain
• No heart failure signs
• Normal initial and 6-12h ECG
• Negative troponins at arrival and 6-12h
• Perform stress test before discharge 2

Kawasaki Disease Recognition

Kawasaki disease can present with atypical gastrointestinal symptoms (vomiting, diarrhea) in infants, making diagnosis challenging—maintain high suspicion when fever persists beyond one week despite treatment 3.

Critical Teaching Point:

• Infants under 6 months are at highest risk for atypical presentations and delayed diagnosis
• Gastrointestinal symptoms (vomiting, diarrhea) may dominate the clinical picture, masking classic mucocutaneous findings
• Echocardiogram is diagnostic when it reveals coronary artery dilation or aortic root dilation
• Treatment: High-dose aspirin plus IV immunoglobulin immediately upon diagnosis
• Delayed diagnosis significantly increases risk of severe cardiovascular complications including coronary artery aneurysms 3

Common Pitfall:

Attributing prolonged fever with GI symptoms to common infections (URI, gastroenteritis) without considering Kawasaki disease, especially in very young infants who may not display the classic five criteria.

USMLE Step 1 Preparation Context

Recent evidence shows that AI-generated questions (ChatGPT-3.5) achieve 83% factual accuracy for Step 1-style questions, though they demonstrate bias toward certain conditions (DVT, MI, thyroid disease) 4. Early exposure to board-style questions during preclinical years significantly improves student confidence and clinical reasoning, with 92.3% of students reporting better preparation when using weekly question sets aligned with their curriculum 5.